A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy
Uterine leiomyosarcomas (ULMS) are a rare cause of uterine malignancy. Due to their aggressive nature, resistance to standard therapy and high rates of recurrence, they are associated with a very poor prognosis, irrespective of their stage at diagnosis. A 68-year-old female, Chinese patient was diag...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Published: |
Elsevier B.V.
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/44863/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Malaya |